Clinical Trial: NCT04461977
Acupuncture for Peripheral Neuropathy Induced by Paclitaxel in Early Stage Breast Cancer
Status:
COMPLETEDPhase:
Not Applicable| Lead Sponsor: | Instituto Brasileiro de Controle do Cancer |
| Information Provided By: | Instituto Brasileiro de Controle do Cancer |
| Last Update Posted: | 2024-05-31 |
Study Overview
Brief Summary
The present study aims to evaluate the effectiveness of acupuncture in the treatment of chemotherapy drug paclitaxel induced peripheral neuropathy in patients with early stage breast cancer
Official Title
Acupuncture for Treatment of Peripheral Neuropathy Induced by Neoadjuvant or Adjuvant Paclitaxel in Early Stage Breast Cancer: a Sham Controlled, Randomized Study
Conditions
Peripheral Neuropathy Due to Chemotherapy
Intervention / Treatment
- Other: True acupuncture
- Other: Sham acupuncture
Other Study ID Numbers
- 26778919.3.0000.0072
Start Date (Actual)
2020-01-30
Primary Completion Date (Actual)
2023-11-07
Study Completion Date (Actual)
2024-03-26
Enrollment (Actual)
60
Study Type
Interventional
Phase
Not Applicable
| Lead Sponsor: | Instituto Brasileiro de Controle do Cancer |
| Information Provided By: | Instituto Brasileiro de Controle do Cancer |
| Last Update Posted: | 2024-05-31 |
Study Overview
Brief Summary
The present study aims to evaluate the effectiveness of acupuncture in the treatment of chemotherapy drug paclitaxel induced peripheral neuropathy in patients with early stage breast cancer
Official Title
Acupuncture for Treatment of Peripheral Neuropathy Induced by Neoadjuvant or Adjuvant Paclitaxel in Early Stage Breast Cancer: a Sham Controlled, Randomized Study
Conditions
Peripheral Neuropathy Due to Chemotherapy
Intervention / Treatment
- Other: True acupuncture
- Other: Sham acupuncture
Other Study ID Numbers
- 26778919.3.0000.0072
Start Date (Actual)
2020-01-30
Primary Completion Date (Actual)
2023-11-07
Study Completion Date (Actual)
2024-03-26
Enrollment (Actual)
60
Study Type
Interventional
Phase
Not Applicable